{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T19:54:11Z","timestamp":1781121251075,"version":"3.54.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"vor","delay-in-days":5358,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1111\/j.1600-6143.2007.02138.x","type":"journal-article","created":{"date-parts":[[2008,3,3]],"date-time":"2008-03-03T19:03:16Z","timestamp":1204570996000},"page":"839-846","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":160,"title":["A Novel Model Measuring the Harm of Transplanting Hepatocellular Carcinoma Exceeding Milan Criteria"],"prefix":"10.1016","volume":"8","author":[{"given":"M.L.","family":"Volk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Vijan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Marrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1600-6143.2007.02138.x_bib1","first-page":"726","article-title":"Hepatic transplantation for primary and metastatic cancers of the liver","volume":"110","author":"Penn","year":"1991","journal-title":"Surgery"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib2","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib3","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/hep.1840160122","article-title":"Natural history of small untreated hepatocellular carcinoma in cirrhosis: A multivariate analysis of prognostic factors of tumor growth rate and patient survival","volume":"16","author":"Barbara","year":"1992","journal-title":"Hepatology"},{"issue":"5 Suppl 1","key":"10.1111\/j.1600-6143.2007.02138.x_bib4","doi-asserted-by":"crossref","first-page":"S277","DOI":"10.1053\/j.gastro.2004.09.042","article-title":"Living donor liver transplantation for hepatocellular carcinoma","volume":"127","author":"Kulik","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib5","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":"Management of hepatocellular carcinoma","volume":"42","author":"Bruix","year":"2005","journal-title":"Hepatology"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib6","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2217::AID-CNCR6>3.0.CO;2-M","article-title":"Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival","volume":"77","author":"Stuart","year":"1996","journal-title":"Cancer"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib7","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib8","doi-asserted-by":"crossref","first-page":"817","DOI":"10.7326\/0003-4819-139-10-200311180-00009","article-title":"The continuing increase in the incidence of hepatocellular carcinoma in the United States: An update","volume":"139","author":"El-Serag","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib9","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/jlts.2002.34892","article-title":"Liver transplantation for hepatocellular carcinoma: Comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria","volume":"8","author":"Yao","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cld.2004.12.007","article-title":"Liver transplantation for hepatocellular carcinoma: Is expansion of criteria justified","volume":"9","author":"Roayaie","year":"2005","journal-title":"Clin Liver Dis"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1055\/s-2006-947295","article-title":"Expanded criteria for hepatocellular carcinoma: Down-staging with a view to liver transplantation\u2013yes","volume":"26","author":"Yao","year":"2006","journal-title":"Semin Liv Dis"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1600-6143.2004.00703.x","article-title":"The survival benefit of liver transplantation","volume":"5","author":"Merion","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib13","unstructured":"UNOS. Policy 3.6, Organ Distribution: Allocation of Livers; revised September 18, 2007."},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib14","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/lt.20304","article-title":"Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: A decision analysis","volume":"10","author":"Amin","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib15","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1111\/j.1600-6143.2006.01508.x","article-title":"Geographic differences in event rates by model for end-stage liver disease score","volume":"6","author":"Roberts","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib16","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1111\/j.1600-6143.2005.01008.x","article-title":"Regional variations in peer reviewed liver allocation under the MELD system","volume":"5","author":"Rodriguez-Luna","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib17","unstructured":"OPTN. 2005 Annual Report. 2005 [cited December 18, 2006]; Available from: http:\/\/www.optn.org\/data\/annualReport.asp. Accessed January 15, 2007."},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib18","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1053\/jhep.2001.23311","article-title":"Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective","volume":"33","author":"Sarasin","year":"2001","journal-title":"Hepatology"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib19","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/lt.20824","article-title":"A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation","volume":"12","author":"Cholongitas","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/0272989X04268956","article-title":"A clinically based discrete-event simulation of end-stage liver disease and the organ allocation process","volume":"25","author":"Shechter","year":"2005","journal-title":"Med Decis Making"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib21","unstructured":"OPTN. 2006 Annual Report. Available from: www.optn.org\/data\/annualReport.asp. Accessed August 12, 2007."},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib22","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/jhep.2003.50047","article-title":"Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival","volume":"37","author":"Llovet","year":"2003","journal-title":"Hepatology"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib23","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1053\/j.gastro.2006.05.021","article-title":"Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients","volume":"131","author":"Takayasu","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0168-8278(98)80187-6","article-title":"Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: A multicenter randomized trial. Groupe CHC","volume":"29","author":"Pelletier","year":"1998","journal-title":"J Hepatol"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib25","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/lt.21095","article-title":"Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: A report from the International Registry of Hepatic Tumors in Liver Transplantation","volume":"13","author":"Onaca","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib26","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/lt.500050404","article-title":"Health-related quality of life after liver transplantation: A meta-analysis","volume":"5","author":"Bravata","year":"1999","journal-title":"Liver Transpl Surg"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib27","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/hec.787","article-title":"An empirical comparison of EQ-5D and SF-6D in liver transplant patients","volume":"12","author":"Longworth","year":"2003","journal-title":"Health Econ"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/jlts.2002.31345","article-title":"Assessing health-related quality of life pre- and post-liver transplantation: A prospective multicenter study","volume":"8","author":"Ratcliffe","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib29","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1023\/B:QURE.0000021685.83961.88","article-title":"Health status versus utilities of patients with end-stage liver disease","volume":"13","author":"Bryce","year":"2004","journal-title":"Qual Life Res"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib30","doi-asserted-by":"crossref","unstructured":"Rhodes R, Battin MP, Silvers A. Medicine and Social Justice: Essays on the Distribution of Health Care. Oxford: Oxford University Press; 2002.","DOI":"10.1093\/oso\/9780195143546.001.0001"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib31","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/0277-9536(95)00216-2","article-title":"Distributing scarce livers: The moral reasoning of the general public","volume":"42","author":"Ubel","year":"1996","journal-title":"Soc Sci Med"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib32","first-page":"19","article-title":"Liver transplantation in the United States: A report from the Organ Procurement and Transplantation Network","author":"Smith","year":"2007","journal-title":"Clin Transpl"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/0272989X04273137","article-title":"A methodological framework for optimally reorganizing liver transplant regions","volume":"25","author":"Stahl","year":"2005","journal-title":"Med Decis Making"},{"issue":"18 Suppl 1","key":"10.1111\/j.1600-6143.2007.02138.x_bib34","article-title":"Sorafenib improves survival in advanced Hepatocellular Carcinoma (HCC): Results of a Phase III randomized placebo-controlled trial (SHARP trial)","volume":"25","author":"Llovet","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib35","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jhep.2005.10.002","article-title":"Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: A population-based study","volume":"44","author":"El-Serag","year":"2006","journal-title":"J Hepatol"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib36","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/lt.20847","article-title":"Optimizing staging for hepatocellular carcinoma before liver transplantation: A retrospective analysis of the UNOS\/OPTN database","volume":"12","author":"Freeman","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib37","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/01.tp.0000258643.05294.0b","article-title":"Genes associated with progression and recurrence of hepatocellular carcinoma in hepatitis C patients waiting and undergoing liver transplantation: Preliminary results","volume":"83","author":"Mas","year":"2007","journal-title":"Transplantation"},{"issue":"4 Suppl 1","key":"10.1111\/j.1600-6143.2007.02138.x_bib38","first-page":"407A","article-title":"Liver transplantation for hepatocellular carcinoma: Validation of the Milan criteria using the UNOS database","volume":"44","author":"Mashoi","year":"2006","journal-title":"Hepatology"},{"issue":"4 Suppl 1","key":"10.1111\/j.1600-6143.2007.02138.x_bib39","first-page":"550A","article-title":"What is the impact of UCSF expansion criteria according to pre-liver transplantation tumor characteristics on survival: Results from 14 French centers","volume":"40","author":"Decaens","year":"2004","journal-title":"Hepatology"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib40","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/00000658-200204000-00012","article-title":"Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters","volume":"235","author":"Roayaie","year":"2002","journal-title":"Ann Surg"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib41","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/SLA.0b013e318148c704","article-title":"Liver transplantation criteria for hepatocellular carcinoma should be expanded: A 22-year experience with 467 patients at UCLA","volume":"246","author":"Duffy","year":"2007","journal-title":"Ann Surg"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib42","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1053\/jhep.2001.24563","article-title":"Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival","volume":"33","author":"Yao","year":"2001","journal-title":"Hepatology"},{"issue":"4 Suppl 1","key":"10.1111\/j.1600-6143.2007.02138.x_bib43","first-page":"191A","article-title":"Liver transplantation for hepatocellular carcinoma: A 5-year prospective study validating expanded criteria applied to pre-operative imaging","volume":"44","author":"Yao","year":"2006","journal-title":"Hepatology"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib44","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/j.1600-6143.2006.01321.x","article-title":"Waiting list removal rates among patients with chronic and malignant liver diseases","volume":"6","author":"Freeman","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib45","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/00007890-200109150-00021","article-title":"Living-donor versus cadaveric liver transplantation for non-resectable small hepatocellular carcinoma and compensated cirrhosis: A decision analysis","volume":"72","author":"Cheng","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib46","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/lt.20012","article-title":"Liver transplantation for hepatocellular carcinoma: The MELD impact","volume":"10","author":"Sharma","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1600-6143.2007.02138.x_bib47","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hep.510290145","article-title":"Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials","volume":"29","author":"Llovet","year":"1999","journal-title":"Hepatology"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-6143.2007.02138.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522056258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522056258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-6143.2007.02138.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:42:49Z","timestamp":1761626569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522056258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S1600613522056258"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-6143.2007.02138.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Novel Model Measuring the Harm of Transplanting Hepatocellular Carcinoma Exceeding Milan Criteria","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1600-6143.2007.02138.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}